Afficher la notice abrégée

dc.rights.licenseopenen_US
dc.contributor.authorSING, Chor-Wing
dc.contributor.authorLIN, Tzu-Chieh
dc.contributor.authorBARTHOLOMEW, Sharon
dc.contributor.authorBELL, J. Simon
dc.contributor.authorBENNETT, Corina
dc.contributor.authorBEYENE, Kebede
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorBOSCO-LEVY, Pauline
dc.contributor.authorCHAN, Amy Hai Yan
dc.contributor.authorCHANDRAN, Manju
dc.contributor.authorCHEUNG, Ching-Lung
dc.contributor.authorDOYON, Caroline Y.
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorDROZ-PERROTEAU, Cecile
dc.contributor.authorGANESAN, Ganga
dc.contributor.authorHARTIKAINEN, Sirpa
dc.contributor.authorILOMAKI, Jenni
dc.contributor.authorJEONG, Han Eol
dc.contributor.authorKIEL, Douglas P.
dc.contributor.authorKUBOTA, Kiyoshi
dc.contributor.authorLAI, Edward Chia-Cheng
dc.contributor.authorLANGE, Jeff
dc.contributor.authorLEWIECKI, E. Michael
dc.contributor.authorLIU, Jiannong
dc.contributor.authorMAN, Kenneth K. C.
dc.contributor.authorMENDES DE ABREU, Mirhelen
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorMOORE, Nicholas
dc.contributor.authorO'KELLY, James
dc.contributor.authorOOBA, Nobuhiro
dc.contributor.authorPEDERSEN, Alma B.
dc.contributor.authorPRIETO-ALHAMBRA, Daniel
dc.contributor.authorSHIN, Ju-Young
dc.contributor.authorSORENSEN, Henrik T.
dc.contributor.authorTAN, Kelvin Bryan
dc.contributor.authorTOLPPANEN, Anna-Maija
dc.contributor.authorVERHAMME, Katia M. C.
dc.contributor.authorWANG, Grace Hsin-Min
dc.contributor.authorWATCHARATHANAKIJ, Sawaeng
dc.contributor.authorZHAO, Hongxin
dc.contributor.authorWONG, Ian C. K.
dc.date.accessioned2021-10-12T12:51:46Z
dc.date.available2021-10-12T12:51:46Z
dc.date.issued2021-07-28
dc.identifier.issn2044-6055en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/112751
dc.description.abstractEnINTRODUCTION: Hip fractures are associated with a high burden of morbidity and mortality. Globally, there is wide variation in the incidence of hip fracture in people aged 50 years and older. Longitudinal and cross-geographical comparisons of health data can provide insights on aetiology, risk factors, and healthcare practices. However, systematic reviews of studies that use different methods and study periods do not permit direct comparison across geographical regions. Thus, the objective of this study is to investigate global secular trends in hip fracture incidence, mortality and use of postfracture pharmacological treatment across Asia, Oceania, North and South America, and Western and Northern Europe using a unified methodology applied to health records. METHODS AND ANALYSIS: This retrospective cohort study will use a common protocol and an analytical common data model approach to examine incidence of hip fracture across population-based databases in different geographical regions and healthcare settings. The study period will be from 2005 to 2018 subject to data availability in study sites. Patients aged 50 years and older and hospitalised due to hip fracture during the study period will be included. The primary outcome will be expressed as the annual incidence of hip fracture. Secondary outcomes will be the pharmacological treatment rate and mortality within 12 months following initial hip fracture by year. For the primary outcome, crude and standardised incidence of hip fracture will be reported. Linear regression will be used to test for time trends in the annual incidence. For secondary outcomes, the crude mortality and standardised mortality incidence will be reported. ETHICS AND DISSEMINATION: Each participating site will follow the relevant local ethics and regulatory frameworks for study approval. The results of the study will be submitted for peer-reviewed scientific publications and presented at scientific conferences.
dc.language.isoENen_US
dc.rightsAttribution-NonCommercial 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc/3.0/us/*
dc.title.enGlobal epidemiology of hip fractures: a study protocol using a common analytical platform among multiple countries
dc.typeArticle de revueen_US
dc.identifier.doi10.1136/bmjopen-2020-047258en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed34321298en_US
bordeaux.journalBMJ Openen_US
bordeaux.pagee047258en_US
bordeaux.volume11en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - UMR 1219en_US
bordeaux.issue7en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.teamPharmacoEpi-Drugsen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-03375055
hal.version1
hal.date.transferred2021-10-12T12:51:53Z
hal.exporttrue
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=BMJ%20Open&rft.date=2021-07-28&rft.volume=11&rft.issue=7&rft.spage=e047258&rft.epage=e047258&rft.eissn=2044-6055&rft.issn=2044-6055&rft.au=SING,%20Chor-Wing&LIN,%20Tzu-Chieh&BARTHOLOMEW,%20Sharon&BELL,%20J.%20Simon&BENNETT,%20Corina&rft.genre=article


Fichier(s) constituant ce document

Thumbnail
Thumbnail

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée